Neurology Central

Could artificial intelligence be used to detect Parkinson’s disease?

Chinese tech firm Tencent (Shenzen, China), British healthcare technology company Medopad (London, UK) and Ray Chaudhuri (National Parkinson Foundation International Centre of Excellence at King’s College London, UK) are working together to develop a new method for assessing motor function in patients with Parkinson’s disease. The collaborative enterprise utilizes artificial intelligence (AI) to improve the efficiency of the motor function assessment process.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.